PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
23-Sep-2025 EMV Capital acquires antibiotic assets from Destiny Pharma EMV Capital, Destiny Pharma
23-Sep-2025 ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK Myricx Bio
23-Sep-2025 BetaGlue Therapeutics Announces the Appointment of Alexis Peyroles as New Chief Executive Officer BetaGlue Therapeutics
23-Sep-2025 Servier receives approval from European Commission for Voranigo® (vorasidenib), first targeted therapy for Patients with Grade 2 IDH-mutant Glioma Servier
23-Sep-2025 Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride) in the UK at a list price equal to the US list price Bristol Myers Squibb
23-Sep-2025 New ublituximab data in multiple sclerosis to be presented at ECTRIMS Congress 2025 alongside partner TG Therapeutics Neuraxpharm Group
23-Sep-2025 Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research Biognosys
23-Sep-2025 Enzene Enables Commercial Supply of Pertuzumab for the Treatment of Breast Cancer Enzene
23-Sep-2025 Advanced workflow automation and scalable image analysis in spatial biology ZEISS and Concept Life Sciences announce partnership ZEISS, Concept Life Sciences
23-Sep-2025 Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE® Rollout Santhera
23-Sep-2025 Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Sanofi
23-Sep-2025 DaltonTx raises £4 million seed financing to build the intelligence backbone of drug discovery DaltonTx
22-Sep-2025 N4 Pharma collaboration with SRI International demonstrates Nuvec® nanoparticle successfully targets lung cancer cells N4 Pharma
22-Sep-2025 Medical Elastomer Market to Reach USD 19.2 Billion by 2032, Driven by Advanced Material Innovations and Expanding Healthcare Applications Acumen Research And Consulting
22-Sep-2025 Abselion Introduces Protein G Total Antibody Quantification Kit Abselion
19-Sep-2025 Celltrion announces commercial availability of Omlyclo™ across Europe at EADV 2025 Celltrion
19-Sep-2025 Microbiotica Announces Completion of Recruitment in its International Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma – Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Microbiotica
18-Sep-2025 electronRx to Launch pDx App for Remote Chronic Respiratory Disease Management electronRx
18-Sep-2025 MedTech Industry Innovators and Investors Call for Urgent Action to Unblock UK MedTech Bottlenecks CPI
18-Sep-2025 Scientist Turns Chronic Illness Into Mission, Launches Privacy-First Nutrigenomics DNA Nutrition Company Noorns